AI assistant
Sending…
Co-Diagnostics, Inc. — Director's Dealing 2021
Sep 22, 2021
35011_dirs_2021-09-22_a3e20a9b-c6d2-4d1c-930d-521a72eed4ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2021-09-08
Reporting Person: Durenard Eugene (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-08 | Common Stock | S | 2000.00 | $10.455 | Disposed | 0.00 | Direct |
More from Co-Diagnostics, Inc.
Capital/Financing Update
2026
May 28
Capital/Financing Update
2026
May 21
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
Feb 11
Regulatory Filings
2026
Jan 21
Delisting Announcement
2026
Jan 13
Share Issue/Capital Change
2025
Dec 30
Capital/Financing Update
2025
Dec 19
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 5